Endometriosis Drugs Global Market Report 2023: Emerging Treatments for Endometriosis & Endometrial Cancer Present Opportunities
DUBLIN, March 10, 2023 /PRNewswire/ -- The "Endometriosis Drugs: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Endometriosis Drugs Market to Reach $3.3 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Endometriosis Drugs estimated at US$2.7 Billion in the year 2022, is projected to reach a revised size of US$3.3 Billion by 2030, growing at a CAGR of 2.6% over the analysis period 2022-2030. Hormone therapy, one of the segments analyzed in the report, is projected to record 3% CAGR and reach US$2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Analgesics segment is readjusted to a revised 2% CAGR for the next 8-year period.
The U.S. Market is Estimated at $777.8 Million, While China is Forecast to Grow at 2.4% CAGR
The Endometriosis Drugs market in the U.S. is estimated at US$777.8 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$580.1 Million by the year 2030 trailing a CAGR of 2.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.
Select Competitors (Total 38 Featured) -
- AbbVie Inc.
- Astellas Pharma Inc.
- AstraZeneca Plc
- Bayer AG
- Debiopharm Group
- Evotec AG
- Kissei Pharmaceutical Co. Ltd.
- Neurocrine Biosciences Inc.
- ObsEva SA
- Pfizer Inc.
- Repros Therapeutics Inc.
- Takeda Pharmaceutical Company Limited
- ValiRx plc
What`s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Endometriosis: An Introductory Prelude
- Recent Market Activity
- Endometriosis Facts in a Nutshell
- Poor Efficacy & Safety Profiles of Existing Drugs Lead to Unmet Medical Needs
- Key Endometriosis Drugs on the Market
- The Pipeline Review
- Key Endometriosis Drugs in the Pipeline: 2017
- Endometriosis Drugs - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Steady Growth Expected Over the Next Few Years
- Emerging Treatment for Endometriosis & Endometrial Cancer
- Global Awareness Campaigns and Efforts
- Uptrend in Healthcare Expenditure Creates Substantial Opportunities
- Developed Regions Remain Primary Revenue Contributors
- Developing Regions Exhibit Immense Growth Potential
- Stable Economic Scenario to Augment Market Prospects
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
A selection of companies mentioned in this report includes
- AbbVie Inc.
- Astellas Pharma Inc.
- AstraZeneca Plc
- Bayer AG
- Debiopharm Group
- Evotec AG
- Kissei Pharmaceutical Co. Ltd.
- Neurocrine Biosciences Inc.
- ObsEva SA
- Pfizer Inc.
- Repros Therapeutics Inc.
- Takeda Pharmaceutical Company Limited
- ValiRx plc
For more information about this report visit https://www.researchandmarkets.com/r/i33luz
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/endometriosis-drugs-global-market-report-2023-emerging-treatments-for-endometriosis--endometrial-cancer-present-opportunities-301769017.htmlSOURCE Research and Markets